Bali Orders Rockeby Biomed Avian Rapid Flu Test By northviews on Aug 31, 2009 in Uncategorized
Australian diagnostic bundle Rockeby biomed Ltd (RBY:AX) has secured a contract to supply its Avian Flu Rapid test to the Indonesian islet of Bali after just out reports of outbreaks of avian flu.
Indonesian farming authorities have ordered 2000 of Rockeby’s tests after hundreds of indifferent chickens onBali were tested unmistakeable suitable the H5N1 extraction of bird flu. ’round 300 birds died of the virus in Bali’s westernmost Jembrana district.
The World Constitution Organism has said that limited hominoid-to-human transmission could have occurred in a subdivision on Sumatra island, the location of the world’s largest cluster of human infections. Indonesian health authorities moved with all speed to cull in a body populations of domestic ducks and chickens on Bali earlier this year after birds became ill.
Rockeby biomed chief big cheese Dr Sze-Wee Tan said the company’s avian flu tests were recognised by the Indonesian authorities as being the most effective in detecting the outbreak of avian flu amongst poultry populations.
“Since our avian flu test obtained the registration approval from the Indonesia Examine Agency two weeks ago, we’ve just received the senior order of 2,000 tests to supply to the private farms for the treatment of this healthy outbreak,” Dr Tan said.
“Our tender use with the Indonesian domination strength agency is still ongoing. ” Rockeby’s avian flu test has received registration enable by the Indonesia authorities and has received the registration license signed by the Director Generale. No more than two tests tease received the license for the benefit of (Vet.) avian flu lightning-fast test in Indonesia to date: Anigen and Rockeby.
Dr Tan, who is an outstanding Singapore public health expert, said Indonesia is taking precautions to control outbreaks of the avian flu and he was actively concerned in training the Indonesia health and veterinary agencies at the Queensland University of Technology during July.
Rockeby is negotiating with a number of health authorities around the world where outbreaks obtain occurred including Italy, Turkey and Romania.
Rockeby biomed:
Rockeby biomed Limited is an ASX-listed (ASX: RBY) Singapore based biotechnology company specializing in research, evolution and marketing of rapid testing technologies for infectious disability in humans and animals.
The company’s core specialization is the maturation of rapid testing diagnostics.
RBY Price at posting:
3.3¢ Sentiment: Hold Disclosure: Held